NOEMI
MANCEÑIDO MARCOS
PROFESOR DOCTOR
![Foto de NOEMI](/img/nophoto.png)
![Foto de Complexo Hospitalario Universitario de Pontevedra](/img/noimage_org.png)
Complexo Hospitalario Universitario de Pontevedra
Pontevedra, EspañaPublicaciones en colaboración con investigadores/as de Complexo Hospitalario Universitario de Pontevedra (10)
2024
-
Efficacy and safety of biological treatment for inflammatory bowel disease in elderly patients: Results from a GETECCU cohort
Gastroenterologia y Hepatologia
2023
-
Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated with Internal Fistulizing Disease: BIOSCOPE Study from GETECCU
American Journal of Gastroenterology, Vol. 118, Núm. 6, pp. 1036-1046
-
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety
American Journal of Gastroenterology, Vol. 118, Núm. 7, pp. 1237-1247
2022
-
Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients
Frontiers in Medicine, Vol. 9
-
Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry
Journal of Clinical Medicine, Vol. 11, Núm. 2
-
Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case–Control Study (COVID-19-EII)
Journal of Clinical Medicine, Vol. 11, Núm. 24
-
Surgery due to Inflammatory Bowel Disease During Pregnancy: Mothers and Offspring Outcomes From an ECCO Confer Multicentre Case Series [Scar Study
Journal of Crohn's & colitis, Vol. 16, Núm. 9, pp. 1428-1435
2021
-
Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry
Journal of Crohn's and Colitis, Vol. 15, Núm. 11, pp. 1846-1851
2015
-
Effectiveness of adalimumab in perianal fistulas in Crohn's disease patients naive to Anti-TNF therapy
Journal of Clinical Gastroenterology, Vol. 49, Núm. 1, pp. 34-40
2011
-
Thiopurine methyl-transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine-treated inflammatory bowel disease patients
Alimentary Pharmacology and Therapeutics, Vol. 34, Núm. 5, pp. 544-554